BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35385171)

  • 21. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.
    Townamchai K; Berkowitz R; Bhagwat M; Damato AL; Friesen S; Lee LJ; Matulonis U; O'Farrell D; Viswanathan AN
    Gynecol Oncol; 2013 Apr; 129(1):18-21. PubMed ID: 23262378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
    Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
    Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
    Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database.
    Nieto K; Adams W; Pham N; Block AM; Grover S; Small W; Harkenrider MM
    Gynecol Oncol; 2018 Jan; 148(1):147-153. PubMed ID: 29129389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
    Orellana TJ; Garrett AA; Soong TR; Rives T; Courtney-Brooks M; Taylor SE; Lesnock J; Berger J; Boisen M; Coffman L; Buckanovich R; Mahdi H; Comerci JC; Beriwal S; Sukumvanich P; Edwards RP; Bhargava R; Olawaiye AB
    Gynecol Oncol; 2023 Mar; 170():77-83. PubMed ID: 36641903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy.
    Smith RS; Kapp DS; Chen Q; Teng NN
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):767-78. PubMed ID: 11020574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
    Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
    Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy of uterine clear cell carcinoma: a review.
    Xu Y; Hanna RK; Elshaikh MA
    Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
    Ma X; Cao D; Zhou H; Wang T; Wang J; Zhang Y; Yu M; Cheng N; Peng P; Yang J; Huang H; Shen K
    World J Surg Oncol; 2023 Mar; 21(1):106. PubMed ID: 36973753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.
    Carcangiu ML; Chambers JT
    Int J Gynecol Pathol; 1995 Jan; 14(1):30-8. PubMed ID: 7883423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
    Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
    Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
    Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
    Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
    Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
    Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
    Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Mar; 152(3):599-604. PubMed ID: 30551884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.